Related Articles
HIV infection and cancer in the era of highly active antiretroviral therapy (Review)
Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infectedc patients from a southern Brazilian population
Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy
Fetal cardiac evaluation in HIV‑positive women under HAART therapy in a Romanian hospital
Farnesyltransferase inhibitors prevent HIV protease inhibitor (lopinavir/ritonavir)-induced lipodystrophy and metabolic syndrome in mice